Skin Health Applications

About entrinsic bioscience

Entrinsic Bioscience is a private, U.S.-based biotech firm founded in 2009, focused on translating amino acid science into functional ingredients and active pharmaceutical ingredients (APIs). Its core asset is a patented discovery platform that maps and validates specific amino acid combinations to selectively modulate proteins, aiming to enhance quality of life across several therapeutic areas. The company operates a platform and partnership business model, working with global partners to commercialize formulations for the self-care and health product markets, positioning itself at the intersection of nutrition, wellness, and targeted therapeutics.

About Sayenza Biosciences

Sayenza Biosciences is pioneering a platform to transform adipose tissue from a discarded byproduct into a standardized, high-quality therapeutic material. The company is targeting a dual market opportunity in large aesthetic/cosmetic procedures and regenerative medicine for conditions like wound healing, osteoarthritis, and alopecia. Led by a surgeon-founder and backed by key opinion leaders in plastic surgery, Sayenza is developing automated processing technology to overcome current limitations in fat grafting, aiming to enable scalable and predictable treatments.

Therapeutic Areas